Treatment-Free Survival, With and Without Toxicity, as a Novel Outcome Applied to Immuno-Oncology Agents in Advanced Renal Cell Carcinoma

Treatment-Free Survival, With and Without Toxicity, as a Novel Outcome Applied to Immuno-Oncology Agents in Advanced Renal Cell Carcinoma

kidneycancer

7 months
61 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Meredith M. Regan,1 Michael B. Atkins,2 Thomas Powles,3 Lillian Werner,4 Charlene Mantia,5 Shuo Yang,6 Jennifer L. Johansen,6 Sumati Rao,6 Kyna M. Gooden,6 David F. McDermott7 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; 2Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; 3Barts Cancer Institute, Queen Mary University of London, Royal Free NHS Trust, London; 4Dana-Farber Cancer Institute, Boston, MA; 5Beth Israel Deaconess Medical Center, Boston, MA; 6Bristol-Myers Squibb, Princeton, NJ; 7Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA Treatment-Free Survival, With and Without Toxicity, as a Novel Outcome Applied to Immuno-Oncology Agents in Advanced Renal Cell Carcinoma 18th International Kidney Cancer Symposium 2019, Miami, FL.

___________

Interview here: https://www.oncologytube.com/video/treatment-free-survival-with-and-without-toxicity

Up Next Autoplay